Across TCGA pan-cancer cohorts, ACTG1P11 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ACTG1P11’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where ACTG1P11 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ACTG1P11 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

BRCA, COAD, and LUAD are the cancer types where ACTG1P11 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ACTG1P11 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.062	.002	6	view →
COAD	Female	IV	−0.105	.002	4	view →
LUAD	All	IV	+0.115	.016	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ACTG1P11 RNA expression & survival · all ACTG1P11 data types